Filing Details
- Accession Number:
- 0001209191-17-033038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-17 16:05:43
- Reporting Period:
- 2017-05-09
- Filing Date:
- 2017-05-17
- Accepted Time:
- 2017-05-17 16:05:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1337553 | Aerie Pharmaceuticals Inc | AERI | Biological Products, (No Disgnostic Substances) (2836) | 203109565 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1589991 | D. Gerald Cagle | C/O Aerie Pharmaceuticals, Inc. 2030 Main Street, Suite 1500 Irvine CA 92614 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-09 | 1,000 | $39.90 | 12,900 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
